Life sciences
Tom is a corporate lawyer with particular experience in the life sciences sector. He advises on equity capital markets transactions, including IPOs and secondary fundraisings, private M&A and public takeovers. Tom acts for private and listed companies and for life sciences teams at brokers and investment banks. Clients value Tom’s pragmatic and commercial approach and his ability to guide them smoothly through transactions.
Tom’s life sciences experience includes advising:
BTG
Advised in relation to its joint underwritten cash box placing in connection with the acquisition of PneumRx, Inc
Novacyt SA
Advised Novacyt SA, a French incorporated diagnostics company with HQ in the UK, on its AIM IPO which constituted a dual listing with the existing listing on Euronext Growth Paris
Northland Capital Partners
Advised in its role as Nomad and broker to Evegen Pharma on its AIM IPO
A FTSE 250 healthcare company
Advised in relation to a private acquisition of a university spin out.
Multi-jurisdictional joint venture
Advised in relation to a multi-jurisdictional joint venture over Finnish pharmaceuticals company
Oriel
Advised in its role as Nomad and broker to Rex Bionics, provider of electronic mobility devices, in relation to an acquisition and re-admission to AIM
BTG
Advised on the pre-pack acquisition of assets of SCM Pharma
BTG
Advised on its £177 million takeover of Biocompatibles plc by way of scheme of arrangement
NetScientific
Advised on its acquisition, placing and Rule 9 waiver
More: Life sciences
Technology
Kalibrate Technologies Plc
Advised in connection with AIM IPO of Kalibrate Technologies Plc, a provider of proprietary software-based products and services to the global petroleum retail industry, and in connection with its subsequent recommended takeover.
Nomad
Advised Nomad in connection with acquisition and readmission to AIM of Rex Bionics, pioneer of the REX Robot technology that enhances the mobility of wheel-chair users and on its subsequent secondary placing.
Nomad
Advised Nomad and joint brokers in connection with AIM IPO of BPO company, Ibex Global Solutions.
More: Technology